Zimmer Partners’s Agilon Health AGL Stock Holding History

Zimmer Partners’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,000	Closed	-$4.06M	–	143
2021 Q2	$4.06M	Buy	+4,000	New	+$3.5M	0.05%	117

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Zimmer Partners's AGL Position: Q3 2021 in Review

Zimmer Partners sold out of Agilon Health (AGL) in Q3 2021, closing a stake of 4,000 shares — an estimated $4.06M sold.

Zimmer Partners first reported a position in AGL in Q2 2021 and held it in 1 quarter. The position peaked at $4.06M in Q2 2021. 102 funds tracked by Wall St. Rank hold AGL as of Q3 2021.

Zimmer Partners reported no remaining Agilon Health position as of Q3 2021 after selling out during the quarter.
Zimmer Partners sold 4,000 Agilon Health shares in Q3 2021, an estimated $4.06M.
Zimmer Partners first reported a position in Agilon Health in Q2 2021 and held it in 1 quarter.
Zimmer Partners's Agilon Health position peaked at $4.06M in Q2 2021.
102 funds tracked by Wall St. Rank held Agilon Health as of Q3 2021.

Based on Zimmer Partners's 13F filing for Q3 2021, filed 15 Nov 2021.